(1R,3aR,4R,5S,7aR)-1-((R)-1,5-Dimethylhexyl)-5-ethylamino-3a,7a-dimethyloctahydroinden-4-ol

ID: ALA2336933

PubChem CID: 71583301

Max Phase: Preclinical

Molecular Formula: C21H41NO

Molecular Weight: 323.57

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN[C@H]1CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@]2(C)[C@H]1O

Standard InChI:  InChI=1S/C21H41NO/c1-7-22-18-12-14-20(5)17(11-13-21(20,6)19(18)23)16(4)10-8-9-15(2)3/h15-19,22-23H,7-14H2,1-6H3/t16-,17-,18+,19+,20-,21+/m1/s1

Standard InChI Key:  BCTHGKAHKJKJRU-OUCVULTDSA-N

Molfile:  

     RDKit          2D

 24 25  0  0  0  0  0  0  0  0999 V2000
   27.4007   -3.6320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4007   -4.4492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1060   -4.8536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1060   -3.2192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8112   -3.6330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8123   -4.4492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5888   -4.7004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0678   -4.0394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5871   -3.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8039   -2.8148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8081   -5.2622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8386   -2.6023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4012   -3.3761    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   30.6377   -2.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2910   -1.9957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1057   -5.6708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.6936   -4.8588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.1853   -3.0379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9844   -2.8669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5320   -3.4734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3311   -3.3025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2806   -4.2510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9853   -4.4512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2781   -4.8608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  5 10  1  1
  6 11  1  6
  9 12  1  0
  9 13  1  6
 12 14  1  0
 12 15  1  6
  3 16  1  1
  2 17  1  1
 14 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 17 23  1  0
 23 24  1  0
M  END

Associated Targets(non-human)

Yarrowia lipolytica (267 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Saccharomyces cerevisiae (19171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nakaseomyces glabratus (9108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 323.57Molecular Weight (Monoisotopic): 323.3188AlogP: 5.00#Rotatable Bonds: 7
Polar Surface Area: 32.26Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.22CX LogP: 5.28CX LogD: 2.60
Aromatic Rings: Heavy Atoms: 23QED Weighted: 0.69Np Likeness Score: 1.97

References

1. König M, Müller C, Bracher F..  (2013)  Stereoselective synthesis of a new class of potent and selective inhibitors of human Δ8,7-sterol isomerase.,  21  (7): [PMID:23433667] [10.1016/j.bmc.2013.01.041]

Source